Clinical Trials Logo
  1. Home
  2. Surgical Site Infection
  3. NCT04256824
  4. Details
NCT04256824 Clinical Trial

Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds

Surgical Site Infection Clinical Trial

Official title:
Triclosan-antibacterial Sutures Efficacy on the Incidence of Surgical Site Infection in Clean-contaminated Wounds; Multi-center, Double Blind, Randomized Study

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04256824
Other study ID # PR2019-27
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date February 5, 2020
Est. completion date January 30, 2024

Study information
Verified date September 2023
Source ClinAmygate
Contact Emad R Issak, Diploma
Phone 00201272228989
Email dr.emad.r.h.issak@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparing the incidence of SSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery

Description:

Comparing the incidence of surgical site infection (SSI) in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in clean-contaminated wound surgery. Also, comparing the post hospital stay.

Recruitment information / eligibility
Status Recruiting
Enrollment 430
Est. completion date January 30, 2024
Est. primary completion date October 10, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: - age: 18-75 - clean-contaminated wound surgery Exclusion Criteria: - Patient has immunodeficiency disorder. - Patient receiving anti-cancer / immunosuppressive therapy. - Patients with established pre-operative infection whether community acquired or hospital acquired either at / remote from the operative site.

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• coated vicryl plus
Coated Polyglactin 910 with Triclosan (coated vicryl plus)
• Vicryl
Coated Polyglactin 910 without Triclosan (vicryl)

Locations
Country Name City State
Egypt Misr Univeristy for Science and Technology Hospital Giza

Sponsors (6)
Lead Sponsor Collaborator
ClinAmygate Al Safwa Hospital, Al Zohour Hospital, Al-Menia Univeristy Hospital, Misr University for Science and Technology, MSKMC Univeristy Hospital

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Ahmed I, Boulton AJ, Rizvi S, Carlos W, Dickenson E, Smith NA, Reed M. The use of triclosan-coated sutures to prevent surgical site infections: a systematic review and meta-analysis of the literature. BMJ Open. 2019 Sep 3;9(9):e029727. doi: 10.1136/bmjope — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Incidence of surgical site infection Incidence of surgical site infection within 30 days 30 days
Secondary Hospital stay duration of hospital stay 30 days
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04096885 - The Inselspital Surgical Cohort Study
Terminated NCT03820648 - Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy N/A
Completed NCT04067843 - Effect of Photodynamic Treatment on Skin Microbiome. Single Center Study N/A
Terminated NCT04042077 - Delafloxacin IV and OS Administration Compared to Best Available Therapy in Patients With Surgical Site Infections Phase 3
Completed NCT05841576 - Anaesthetic Management Guided by COMET Measurements N/A
Withdrawn NCT05338281 - NPWT for Abdominal Incisions in DIEP Reconstructions: A RCT N/A
Recruiting NCT03042091 - Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery Early Phase 1
Completed NCT01697748 - Prospective Study on Cesarean Wound Outcomes N/A
Terminated NCT01789697 - Text Message Study N/A
Recruiting NCT05966961 - Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
Recruiting NCT05077592 - Addition of Pre-wound Closure Povidone Iodine Wash Versus Direct Wound Closure Effect on Surgical Site Infections Phase 4
Recruiting NCT05763602 - PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study) Phase 4
Recruiting NCT05502380 - Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery Phase 3
Recruiting NCT03221023 - Intrawound Vancomycin Prophylaxis for Neural Stimulator Phase 2/Phase 3
Completed NCT03257202 - Topical Treatment and Prevalence of P. Acnes Phase 2
Completed NCT06154720 - Surgical Site Infection After Episiotomy Repair Related to Routine Use of Antibiotic Prophylaxis in Low-Risk Population
Not yet recruiting NCT06465901 - A Stratified, Multi-ARm, muLti-site Randomised Platform Trial Aiming to Reduce the INcidence of Post-operative SSI N/A
Not yet recruiting NCT04820075 - Efficacy of an Intervention to Improve the Preoperative Shower in Scheduled Surgery N/A
Recruiting NCT03561376 - Zinc Oxide Versus Petrolatum Following Skin Surgery Early Phase 1
Not yet recruiting NCT04496180 - Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy N/A